2018 Webcasts

MONDAY 9 JULY




Andy Cope



Sir John Stebbings Lecture: Increasing demands at work for everyone – can we still be happy?

1A ARTIFICIAL INTELLIGENCE




Martin Fergie:​



AI an aid to risk prediction / screening​

2A MANAGING HARM




Andy Evans



Introduction




Roger Blanks:​



Variation in recall and biopsy rates nationally (benefit versus harm)




Julietta Patnick:​​



Update on Age Extension Trial​




Nisha Sharma:



B3 guidelines – practical update and new data​




Michael Douek:​



AXILLA – minimising intervention

2B PROFFERED PAPERS​




Jennifer Oduko:​



NHSBSP survey of radiation dose in breast tomosynthesis 2017




Sarah Savaridas:​



Symptomatic recall in the fatty breast: is it necessary?




Nikhil Patel:​



Predicting axillary node metastases in breast cancer: sonographic features and tumour characteristics




Tania Palicastro:



Ultrasound accuracy in predicting residual tumour size after neoadjuvant chemotherapy (NACT) in different breast cancer subtypes




Rhonda Joy Sweeney:​



Mammographic image quality: Do radiographers and radiologists demonstrate comparable knowledge and preferences for positioning standards and criteria?

3A TARGETING BREAST CANCER CARE WITH MRI​




Christopher Comstock:​



MRI in Screening: Abbreviated MRI




Thomas Helbich:​



Preoperative MRI in targeting breast cancer care




Liz O’Flynn:​



Radiogenomics personalising treatment – where are we?

3B MAMMOGRAPHY PRACTICE: STATE OF THE ART AND BEYOND​




Claire Mercer:​



Evidence based techniques for positioning and compression – how does this link with PGMI?




Judith Kelly:​



Image quality in interpretation of FFDM




Helen Yule:​



Tomosynthesis practices for mammographers




Dawn McDonald:​

 

The significance of breast density, and my mission working as a Consultant Radiographer in Ghana

4 STAY ON THE RIGHT SIDE OF THE LAW




Richard Furniss:​



The law, what’s new?​




Mark Sibbering:​



Lessons from the Paterson Case




Ros Given-Wilson:​



Duty of candour and the breast team – guidelines and toolbox




Innocent or guilty? Panel discussion ​



TUESDAY 10 JULY

5 JOINT PLENARY WITH ASSOCIATION OF BREAST CLINICIANS




Liz O’Riordan:​



Inaugural Dr Audrey Tucker Lecture: It’s the little things that matter

6A PROFFERED PAPERS




Roberta Maroni:​



Evaluating the impact of the NHS Breast Screening Programme on mortality from breast cancer in England: a case-control study




Patsy Whelehan: ​



Women’s experiences of mammography: analysis of 1196 free-text comments from a questionnaire study




Nerys Forester:​



5 year prospective follow up of patients with B3 lesions




Alan Tan:​



Difference in tumour characteristics between true interval and screen-detected breast cancers




Lyn Jones:​



Comparison of performance of mammogram readers with breast magnetic resonance imaging (MRI) readers at an abbreviated breast MRI (FAST MRI) interpretation task: Results from a single centre multi-reader study using an enhanced data-set

6B ASSOCIATION OF BREAST CLINICIANS




Christopher Comstock:​



Population screening with MRI: is it the future?




Kate Gower Thomas:



What challenges face the NHSBSP in introducing MRI

7A TECHNIQUES FOR LESION LOCALISATION




Leena Chagla: ​



Radio-guided isotope occult lesion localisation (ROLL)




Henry Cain:



Radioactive seed localisation (RSL)




Jenny Rusby:​



Magnetic seed localisation




Chris Holcombe:​



No innovation without evaluation

7B ASSOCIATION OF BREAST CLINICIANS




Zoe Goldthorpe:​



Mistakes happen we are all human – the human factor




Jim Steel:



Breast Screening Information System (BSIS): what it means and how to use it to be even better

7C CHANNELLING YOUR INNER INVESTIGATOR




Sue Johnson:​



Why do research – a view from the SCoR




Anthony Maxwell:​



Why do research – a view from the BSBR




Sue Williams:​



Case study




Sarah Savaridas:​



Case study




Beverley Scragg:​



Case study




Maggie Wilcox:​



Public and patient involvement in research

8A STRATIFIED SCREENING AND SURVEILLANCE​




Fiona Gilbert:​



Radio-guided isotope occult lesion localisation (ROLL)




Sarah Vinnicombe:



Breast density and texture imaging markers




Andy Evans:



Surveillance following breast cancer

8B ASSOCIATION OF BREAST CLINICIANS




Gareth Evans



Single Nucleotide Polymorphisms (SNPs) – who will benefit and who will lose out?




Andrew Wardley



Update on antibody therapies and the effects of
Rapid BRCA testing on the choice and timings of
chemotherapy regimens